About Qidni labs

About company

Over two million patients around the world suffer from End Stage Renal Disease (ESRD). Patients' survival depends on dialysis, a renal replacement therapy that they undergo until they receive a kidney transplant. The survival rate of patients under dialysis is less than 40% in 5 years (1). A year of dialysis of each patient may cost upwards of $60,000 in Canada and the United States. Patients endure a lot more hardships due to complications and lifestyle restrictions. Studies show that longer treatment times can potentially be associated with prolonged survival.